Cargando…
A Case Report of a Patient with Hereditary Hemorrhagic Telangiectasia Treated Successively with Thalidomide and Bevacizumab
Hereditary hemorrhagic telangiectasia is characterized by mucocutaneous and visceral telangiectasia and involves several organs with vascular malformations. It is an autosomal dominant disease and is distinguished into three types, which are due to mutations in different genes. The common symptom is...
Autores principales: | Amanzada, Ahmad, Töppler, Gwen-Jana, Cameron, Silke, Schwörer, Harald, Ramadori, Giuliano |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3100268/ https://www.ncbi.nlm.nih.gov/pubmed/21611144 http://dx.doi.org/10.1159/000323152 |
Ejemplares similares
-
Safety of thalidomide and bevacizumab in patients with hereditary hemorrhagic telangiectasia
por: Buscarini, Elisabetta, et al.
Publicado: (2019) -
Cerebellar Ataxia with Complete Clinical Recovery and Resolution of MRI Lesions Related to Central Pontine Myelinolysis: Case Report and Literature Review
por: Dolciotti, Cristina, et al.
Publicado: (2010) -
A Rare Case of Toxic Epidermal Necrolysis with Unexpected Fever Resulting from Dengue Virus
por: Grieb, Gerrit, et al.
Publicado: (2010) -
Nodular-Type Lichen Myxedematosus: A Case Report
por: Ogita, Azusa, et al.
Publicado: (2010) -
Sequential Acral Lentiginous Melanomas of the Foot
por: Uehara, Jiro, et al.
Publicado: (2010)